Botanical species · safety record

Steganotaenia araliacea

The EFSA Compendium of Botanicals holds 14 constituent measurements for Steganotaenia araliacea. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Steganotaenia araliacea Hochst.

14Constituent measurements
0Safety records
5Cited sources
0Licensed products (Canada)

Regulatory presence

No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.

What the records describe

Constituents measured

  • Coumarins2
  • Lignans2
  • 10-demethoxystegane1
  • Alkaloids1
  • Apiole1
  • Cardenolides1
  • Myristicin1
  • Prestegane b1
  • Saponins1
  • Scoparone1

Plant parts

  • Seed7
  • Unspecified4
  • Bark2
  • Roots and other underground parts1

Preparations

  • Solvent extraction14

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
10-demethoxysteganeUnspecifiedSolvent extractionHPLC-UVResolve DOI
LignansBarkSolvent extractionGelpermeation, High Performance Thin Layer Chromatography (HPTLC)Resolve DOI
LignansUnspecifiedSolvent extractionGelpermeation, High Performance Thin Layer Chromatography (HPTLC)Resolve DOI
Prestegane bUnspecifiedSolvent extractionNuclear Magnetic Resonance (NMR)Resolve DOI
SteganacinBarkSolvent extractionGelpermeation, High Performance Thin Layer Chromatography (HPTLC)Resolve DOI
SteganoneUnspecifiedSolvent extractionNuclear Magnetic Resonance (NMR)Resolve DOI
AlkaloidsSeedSolvent extractionNo resolvable identifier
ApioleSeedSolvent extractionGC-MSNo resolvable identifier
CardenolidesSeedSolvent extractionNo resolvable identifier
CoumarinsRoots and other underground partsSolvent extractionNo resolvable identifier
CoumarinsSeedSolvent extractionNo resolvable identifier
MyristicinSeedSolvent extractionGC-MSNo resolvable identifier
SaponinsSeedSolvent extractionNo resolvable identifier
ScoparoneSeedSolvent extractionGC-MSNo resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. Demoz, Mussie Sium., Gachoki, Kareru Patrick., Mungai, Keriko Joseph., Negusse, Berhane Girmay. GC-MS analysis of the essential oil and methanol extract of the seeds of Steganotaenia araliacea hochst. American journal of plant sciences, 2014, vol. 5, no. 26), 3752-376, p. 10 pp.
  2. Oryema, Christine., Ziraba, Remigius Bukenya., Odyek, Olwa., Omagor, Nelson., Opio, Alfonse. Phytochemical properties and toxicity to brine shrimp of medicinal plants in Erute county, Lira district, Uganda. Journal of medicinal plants research, 2011, vol. 5, no. 22, p. 5450-5457.
  3. WICKRAMARATNE, DBM., PENGSUPARP, T., MAR, W., CHAI, HB., CHAGWEDERA, TE., BEECHER, CWW., FARNSWORTH, NR., KINGHORN, AD., PEZZUTO, JM., CORDELL, GA. NOVEL ANTIMITOTIC DIBENZOCYCLO-OCTADIENE LIGNAN CONSTITUENTS OF THE STEM BARK OF STEGANOTAENIA-ARALIACEA . Journal of natural products, 1993, vol. 56, no. 12, p. 2083-2090. DOI
  4. KUPCHAN, SM., BRITTON, RW., ZIEGLER, MF., GILMORE, CJ., RESTIVO, RJ., BRYAN, RF. TUMOR INHIBITORS .80. STEGANACIN AND STEGANANGIN, NOVEL ANTILEUKEMIC LIGNAN LACTONES FROM STEGANOTAENIA-ARALIACEA . Journal of the american chemical society, 1973, vol. 95, no. 4, p. 1335-1336. DOI
  5. Meragelman, KM., McKee, TC., Boyd, MR. 10-demethoxystegane, a new lignan from Steganotaenia araliacea. Journal of natural products, 2001, vol. 64, no. 11, p. 1480-1482. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue